FDA Approves Dupixent (dupilumab) for Eczema

March 28, 2017 -- The U.S. Food and Drug Administration today approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is intended for patients whose eczema is not controlled adequately by...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news